Sort   by:  
 Page size 
TranscriptomicsmiRNA profiling of rhabdomyosarcoma-derived exosomes compared to donor cells, using the Affymetrix GeneChip miRNA 3.0 array
Exosomes were isolated by differential centrifugation from the fusion negative human embryonal rhabdomyosarcoma (ERMS) cell lines (JR1, Rh36, and RD) and fusion positive alveolar RMS (ARMS) cell lines (Rh30 and Rh41) and characterized by western blot for exosomal markers. miRNA content of the RMS-de...
ORGANISM(S): Homo sapiens 
2016-12-01 | E-MTAB-5321 | biostudies-arrayexpress
UnknownGeneration of precision preclinical cancer models using regulated in vivo base editing.
Not available
S-EPMC11295146 | biostudies-literature
TranscriptomicsA histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice.
Wildtype and set2delta strains, with samples taken at t=0 and following 30 minutes treatment with 5 µg/ml bleomycin.
ORGANISM(S): Schizosaccharomyces pombe 
2014-06-09 | E-MTAB-2549 | biostudies-arrayexpress
UnknownOverall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.
Not available
S-EPMC6804912 | biostudies-literature
UnknownThe clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders.
Not available
S-EPMC10393417 | biostudies-literature
UnknownCSHP Professional Practice Conference 2019: Poster Abstracts
Not available
S-EPMC6391241 | biostudies-literature
Genomicsena-DATASET-UAMS-11-05-2018-20:15:20:859-1971 - samples
Tumor DNA was extracted from 100 bone marrow aspirate samples where CD138+ selection had been performed to enrich plasma cells from patients with multiple myeloma. Patient matched control DNA from either peripheral blood leukocytes or CD34+ stem cell harvests was also isolated. Both tumor and contro...
EGAD00001004117 | EGA
GenomicsGenomic alterations in MM - CEL
RNA from the same tumor sample (n=98) was also processed using the 3' IVT kit (Affymetrix) and hybridized to U133 Plus 2.0 arrays (Affymetrix).
EGAD00010001577 | EGA
GenomicsTargeted panel data for newly diagnosed myeloma patients.
Genomic abnormalities in MM are common and can affect a patients outcome. Here we have performed targeted sequencing on xx patient tumor samples and matched control DNA. The targeted panel consists of ~160 genes and copy number regions, as well as key regions of chromosomal translocation including ...
EGAS00001002859 | EGA
UnknownFinal, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Not available
S-EPMC12080919 | biostudies-literature
Sort   by:  
 Page size